Cheng, Yi-Hsien
Pal, Arindom
Moody, Rebecca
Heimbach, Tycho
Lukacova, Viera
Patel, Nikunjkumar
Rullo, Gregory
Xu, Yunming
Ahmed, Tausif
Kerwash, Essam
Fang, Lanyan
Article History
Received: 15 December 2024
Accepted: 15 April 2025
First Online: 29 May 2025
Declarations
:
: V. Lukacova is an employee and holds stock of Simulations Plus, Inc. N. Patel was an employee of Certara at the time of this workshop and held stock of Certara, Inc. G. Rullo is an employee and has ownership, options, and interest in stock of AstraZeneca. The other authors have no conflicts of interest to declare.